Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice

The recent Ebola virus (EBOV) epidemic in West Africa demonstrates the potential for a significant public health burden caused by filoviral infections. No vaccine or antiviral is currently FDA approved. To expand the vaccine options potentially available, we assessed protection conferred by an EBOV...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Virol
Hauptverfasser: Lennemann, Nicholas J., Herbert, Andrew S., Brouillette, Rachel, Rhein, Bethany, Bakken, Russell A., Perschbacher, Katherine J., Cooney, Ashley L., Miller-Hunt, Catherine L., Ten Eyck, Patrick, Biggins, Julia, Olinger, Gene, Dye, John M., Maury, Wendy
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2017
Schlagworte:
Vaccines and Antiviral Agents
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5553159/
https://ncbi.nlm.nih.gov/pubmed/28615211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00479-17
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge